Summary:
A Multicenter, Randomized, Flexible-dose, Double-blind Trial of Brexpiprazole Versus Placebo for the Treatment of Adults With Borderline Personality Disorder
Qualified Participants Must:
18 to 65
Not currently receiving or within 60 days received psychotherapy specifically for Borderline Personality Disorder
Qualified Participants May Receive:
Investigational medication and compensation for time and travel